These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 30995069)

  • 1. The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach.
    Jensen EA; Dysart K; Gantz MG; McDonald S; Bamat NA; Keszler M; Kirpalani H; Laughon MM; Poindexter BB; Duncan AF; Yoder BA; Eichenwald EC; DeMauro SB
    Am J Respir Crit Care Med; 2019 Sep; 200(6):751-759. PubMed ID: 30995069
    [No Abstract]   [Full Text] [Related]  

  • 2. Revisiting the Definition of Bronchopulmonary Dysplasia: Effect of Changing Panoply of Respiratory Support for Preterm Neonates.
    Isayama T; Lee SK; Yang J; Lee D; Daspal S; Dunn M; Shah PS;
    JAMA Pediatr; 2017 Mar; 171(3):271-279. PubMed ID: 28114678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.
    Ehrenkranz RA; Walsh MC; Vohr BR; Jobe AH; Wright LL; Fanaroff AA; Wrage LA; Poole K;
    Pediatrics; 2005 Dec; 116(6):1353-60. PubMed ID: 16322158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiology and Predictors of Impaired Gas Exchange in Infants with Bronchopulmonary Dysplasia.
    Svedenkrans J; Stoecklin B; Jones JG; Doherty DA; Pillow JJ
    Am J Respir Crit Care Med; 2019 Aug; 200(4):471-480. PubMed ID: 30789787
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program.
    Poindexter BB; Feng R; Schmidt B; Aschner JL; Ballard RA; Hamvas A; Reynolds AM; Shaw PA; Jobe AH;
    Ann Am Thorac Soc; 2015 Dec; 12(12):1822-30. PubMed ID: 26397992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants.
    Bamat N; Fierro J; Mukerji A; Wright CJ; Millar D; Kirpalani H
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012778. PubMed ID: 34847243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of Bronchopulmonary Dysplasia Among Very Preterm Infants in the United States.
    Jensen EA; Edwards EM; Greenberg LT; Soll RF; Ehret DEY; Horbar JD
    Pediatrics; 2021 Jul; 148(1):. PubMed ID: 34078747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants.
    Subramaniam P; Ho JJ; Davis PG
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001243. PubMed ID: 34661278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants.
    Laughon MM; Langer JC; Bose CL; Smith PB; Ambalavanan N; Kennedy KA; Stoll BJ; Buchter S; Laptook AR; Ehrenkranz RA; Cotten CM; Wilson-Costello DE; Shankaran S; Van Meurs KP; Davis AS; Gantz MG; Finer NN; Yoder BA; Faix RG; Carlo WA; Schibler KR; Newman NS; Rich W; Das A; Higgins RD; Walsh MC;
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1715-22. PubMed ID: 21471086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
    Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Tauscher MK; Murthy V; Ali SKM; Yossuck P; Clark HW; Soll RF; Carlin JB; Davis PG;
    JAMA; 2021 Dec; 326(24):2478-2487. PubMed ID: 34902013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018.
    Bell EF; Hintz SR; Hansen NI; Bann CM; Wyckoff MH; DeMauro SB; Walsh MC; Vohr BR; Stoll BJ; Carlo WA; Van Meurs KP; Rysavy MA; Patel RM; Merhar SL; Sánchez PJ; Laptook AR; Hibbs AM; Cotten CM; D'Angio CT; Winter S; Fuller J; Das A;
    JAMA; 2022 Jan; 327(3):248-263. PubMed ID: 35040888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
    JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001145. PubMed ID: 29063594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low Gestational Age: A Prospective Cohort Study.
    Keller RL; Feng R; DeMauro SB; Ferkol T; Hardie W; Rogers EE; Stevens TP; Voynow JA; Bellamy SL; Shaw PA; Moore PE;
    J Pediatr; 2017 Aug; 187():89-97.e3. PubMed ID: 28528221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Home Oxygen and 2-Year Outcomes of Preterm Infants With Bronchopulmonary Dysplasia.
    DeMauro SB; Jensen EA; Bann CM; Bell EF; Hibbs AM; Hintz SR; Lorch SA
    Pediatrics; 2019 May; 143(5):. PubMed ID: 30975699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002057. PubMed ID: 29035425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pulmonary score for assessing the severity of neonatal chronic lung disease.
    Madan A; Brozanski BS; Cole CH; Oden NL; Cohen G; Phelps DL
    Pediatrics; 2005 Apr; 115(4):e450-7. PubMed ID: 15805348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.